South African health officials said Sunday they’re pausing the country’s rollout of AstraZeneca’s coronavirus vaccine after a study showed it offered reduced protection from the Covid-19 variant first identified there.
South Africa pauses AstraZeneca vaccine rollout after study shows it offers less protection against variant